What is Hyperfine, Inc. (HYPR) stock price today?

Hyperfine, Inc. (HYPR) is currently trading at $0.93, down 1% today.

What is HYPR P/E ratio?

Hyperfine, Inc.'s P/E ratio is -2.33. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is HYPR return on equity (ROE)?

Hyperfine, Inc.'s return on equity (ROE) is -100.30%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Hyperfine, Inc.'s market cap?

Hyperfine, Inc. has a market capitalization of $78.38M.

NASDAQ · Medical - Devices

Hyperfine, Inc. (HYPR) Stock

$0.93 -1.00% NASDAQ: HYPR Healthcare

Valuation

Metric	Value
Price	$0.93
Market Cap	$78.38M
P/E Ratio	-2.33
P/B Ratio	2.43
P/S Ratio	4.55
EPS (TTM)	$-0.43
52-Week High	$2.22
52-Week Low	$0.75
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-100.30%
ROA	-55.32%
ROCE	-62.98%
Gross Margin	-264.29%
Operating Margin	-264.29%
Net Margin	-210.75%
Debt/Equity	0.36
Current Ratio	4.25

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$1.0M	$7.0M	$11.0M	$13.0M	$14.0M
Operating Profit	$-65.0M	$-74.0M	$-48.0M	$-43.0M	$-37.0M
Net Profit	$-65.0M	$-73.0M	$-44.0M	$-41.0M	$-36.0M
EPS	$-0.92	$-1.04	$-0.62	$-0.56	$-0.43
Op Margin	-4336.1%	-1084.2%	-436.1%	-335.3%	-273.4%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$202.0M	$134.0M	$94.0M	$59.0M	$55.0M
Total Liabilities	$16.0M	$10.0M	$10.0M	$10.0M	$14.0M
Cash	$188.0M	$118.0M	$75.0M	$38.0M	$35.0M
Borrowings	$0	$0	$0	$0	$0

Latest News

Hyperfine launches next-generation Swoop MRI system in Europe Hospital Management · Jul 2, 2026 Hyperfine Announces European Launch of Next-Generation Swoop® System Business Wire · Jul 1, 2026 Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care Business Wire · Jun 22, 2026 Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care Business Wire · Jun 18, 2026 Hyperfine, Forward Industries, Sharplink Set for Russell Index Inclusion MT Newswires · May 26, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-47.0M	$-72.0M	$-42.0M	$-39.0M	$-28.0M
Investing Cash Flow	$-5.0M	$-1.0M	$-2.0M	$-1.0M	$-2.0M
Financing Cash Flow	$145.0M	$0	$0	$0	$0
Net Cash Flow	$127.0M	$-73.0M	$-42.0M	$-38.0M	$-2.0M
Free Cash Flow	$-50.0M	$-73.0M	$-43.0M	$-39.0M	$-29.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.07
EV / EBITDA	-1.39
FCF Yield	-36.57%
Quick Ratio	5.45
Interest Coverage	-54.57
Return 1Y	29.19%
Return 3Y	-55.36%
Return 5Y	-89.48%

Ownership

Insiders Held4.81%

Institutions Held14.67%

Institutions Float Held15.42%

Institutional Holder	Shares	Report Date
Vanguard Capital Management LLC	3,453,163	2026-03-31
Fosun International Ltd	1,742,020	2026-03-31
Catalio Capital Management, LP	1,320,041	2026-03-31
Sio Capital Management, LLC	1,000,000	2026-03-31
Geode Capital Management, LLC	955,260	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CNTBConnect Biopharma Holdings Limited	$0.87	-1.21%	-1.05	$54.78M	0.00%
EDAPEdap Tms S.a.	$4.76	-0.52%	-6.63	$178.23M	0.00%
FONR	$19.09	+0.00%	15.33	$117.76M	0.00%
IMAImageneBio, Inc.	$4.24	-0.47%	-0.87	$47.82M	0.00%
LUNGPulmonx Corporation	$1.84	+1.66%	-1.63	$77.72M	0.00%

About Hyperfine, Inc.

Hyperfine, Inc. is led by CEO Maria Degois-Sainz, employs 111 people, headquartered in US, publicly traded since 2021.

Hyperfine, Inc. (HYPR) stock trades at $0.93 with a market capitalization of $78.38M. The stock is valued at a price-to-earnings (P/E) ratio of -2.33, price-to-book of 2.43, price-to-sales of 4.55. Over the past 52 weeks the stock has ranged between $0.75 and $2.22, and currently trades 58.1% below its 52-week high.

On profitability, Hyperfine, Inc. generates a return on equity (ROE) of -100.30%, return on capital employed of -62.98%, an operating margin of -264.29%, a net profit margin of -210.75%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides